Valentina Noemi Madia

Prof. Valentina Noemi Madia

Department of Science, Roma Tre University, Rome, Lazio, Italy
+1
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 July 2021 in Molecules
Verified
Journal Article
Open access
PDF file
Valentina Noemi MadiaValentina Noemi Madia
Valentina Noemi Madia
Daniela De VitaDaniela De Vita
Daniela De Vita
DIDavide Ialongo
Davide Ialongo
VTValeria Tudino
Valeria Tudino
ALAlessandro De Leo
Alessandro De Leo
Antonella MessoreAntonella Messore
Antonella Messore
Growing attention to environmental protection leads food industries to adopt a model of “circular economy” applying safe and sustainable technologies to recover, recycle and valorize by-products. Therefore, by-products become raw material for other industries. Tomato processing industry produces significant amounts of by-products, consisting of skins and seeds. Tomato skin is very rich in lycopene, and from its seeds, high nutritional oil can be extracted. Alternative use of the two fractions not only could cut disposal costs but also allow one to extract bioactive compounds and an oil with a high nutritional value. This review focused on the recent advance in extraction of lycopene, whose beneficial effects on health are widely recognized.

28 January 2015 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
GCGiuliana Cuzzucoli Crucitti
Giuliana Cuzzucoli Crucitti
MMMathieu Métifiot
Mathieu Métifiot
LPLuca Pescatori
Luca Pescatori
AMAntonella Messore
Antonella Messore
Valentina Noemi MadiaValentina Noemi Madia
Valentina Noemi Madia
RSRoberto Di Santo
Roberto Di Santo

1 January 2017 in Journal of Enzyme Inhibition and Medicinal Chemistry
Verified
Journal Article
Open access
Francesco SaccolitiFrancesco Saccoliti
Francesco Saccoliti
GAGabriella Angiulli
Gabriella Angiulli
GPGiovanni Pupo
Giovanni Pupo
LPLuca Pescatori
Luca Pescatori
Valentina Noemi MadiaValentina Noemi Madia
Valentina Noemi Madia
AIAndrea Ilari
Andrea Ilari
The study presented here aimed at identifying a new class of compounds acting against Leishmania parasites, the causative agent of Leishmaniasis. For this purpose, the thioether derivatives of our in-house library have been evaluated in whole-cell screening assays in order to determine their in vitro activity against Leishmania protozoan. Among them, promising results have been achieved with compound RDS 777 (6-(sec-butoxy)-2-((3-chlorophenyl)thio)pyrimidin-4-amine) (IC50 = 29.43 µM), which is able to impair the mechanism of the parasite defence against the reactive oxygen species by inhibiting the trypanothione reductase (TR) with high efficiency (Ki 0.25 ± 0.18 µM). The X-ray structure of L. infantum TR in complex with RDS 777 disclosed the mechanism of action of this compound that binds to the catalytic site and engages in hydrogen bonds the residues more involved in the catalysis, namely Glu466', Cys57 and Cys52, thereby inhibiting the trypanothione binding and avoiding its reduction.

31 March 2014 in Journal of Medicinal Chemistry
Verified
Journal Article
Open access
Roberta CostiRoberta Costi
Roberta Costi
MMMathieu Métifiot
Mathieu Métifiot
SCSuhman Chung
Suhman Chung
GCGiuliana Cuzzucoli Crucitti
Giuliana Cuzzucoli Crucitti
KMKasthuraiah Maddali
Kasthuraiah Maddali
RSRoberto Di Santo
Roberto Di Santo
A series of antiviral basic quinolinonyl diketo acid derivatives were developed as inhibitors of HIV-1 IN. Compounds 12d,f,i inhibited HIV-1 IN with IC50 values below 100 nM for strand transfer and showed a 2 order of magnitude selectivity over 3′-processing. These strand transfer selective inhibitors also inhibited HIV-1 RNase H with low micromolar potencies. Molecular modeling studies based on both the HIV-1 IN and RNase H catalytic core domains provided new structural insights for the future development of these compounds as dual HIV-1 IN and RNase H inhibitors.

11 May 2015 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
LPLuca Pescatori
Luca Pescatori
MMMathieu Métifiot
Mathieu Métifiot
SCSuhman Chung
Suhman Chung
TMTakashi Masoaka
Takashi Masoaka
GCGiuliana Cuzzucoli Crucitti
Giuliana Cuzzucoli Crucitti
RSRoberto Di Santo
Roberto Di Santo

9 March 2021 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
Valentina Noemi MadiaValentina Noemi Madia
Valentina Noemi Madia
MAMarta De Angelis
Marta De Angelis
Daniela De VitaDaniela De Vita
Daniela De Vita
Antonella MessoreAntonella Messore
Antonella Messore
ALAlessandro De Leo
Alessandro De Leo
Roberta CostiRoberta Costi
Roberta Costi
The resinous exudate produced by Commiphora myrrha (Nees) Engl. is commonly known as true myrrh and has been used since antiquity for several medicinal applications. Hundreds of metabolites have been identified in the volatile component of myrrh so far, mainly sesquiterpenes. Although several efforts have been devoted to identifying these sesquiterpenes, the phytochemical analyses have been performed by gas-chromatography/mass spectrometry (GC–MS) where the high temperature employed can promote degradation of the components. In this work, we report the extraction of C. myrrha by supercritical CO2, an extraction method known for the mild extraction conditions that allow avoiding undesired chemical reactions during the process. In addition, the analyses of myrrh oil and of its metabolites were performed by HPLC and GC–MS. Moreover, we evaluated the antiviral activity against influenza A virus of the myrrh extracts, that was possible to appreciate after the addition of vitamin E acetate (α-tocopheryl acetate) to the extract. Further, the single main bioactive components of the oil of C. myrrha commercially available were tested. Interestingly, we found that both furanodienone and curzerene affect viral replication by acting on different steps of the virus life cycle.